LAN2H_RUMFL
ID LAN2H_RUMFL Reviewed; 65 AA.
AC P0DQM0;
DT 12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT 12-AUG-2020, sequence version 1.
DT 25-MAY-2022, entry version 4.
DE RecName: Full=Lantipeptide Flvbeta.h {ECO:0000303|PubMed:27028884};
DE Flags: Precursor;
GN Name=FlvA2.h {ECO:0000303|PubMed:27028884};
OS Ruminococcus flavefaciens.
OC Bacteria; Firmicutes; Clostridia; Eubacteriales; Oscillospiraceae;
OC Ruminococcus.
OX NCBI_TaxID=1265;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], EXPRESSION IN E.COLI, DEHYDRATION AT
RP THR-28; SER-30 AND THR-44, AND LANTHIONINE AND METHYLLANTHIONINE
RP CROSS-LINKS.
RC STRAIN=FD-1;
RX PubMed=27028884; DOI=10.1016/j.chembiol.2015.11.014;
RA Zhao X., van der Donk W.A.;
RT "Structural characterization and bioactivity analysis of the two-component
RT lantibiotic Flv system from a ruminant bacterium.";
RL Cell Chem. Biol. 23:246-256(2016).
CC -!- FUNCTION: Lanthionine-containing peptide that does probably not show
CC antibacterial activity, since its analog [+2]Flvbeta.h does not show
CC antibacterial activity against M.luteus (PubMed:27028884). Also does
CC not show antibiotic activity when tested with [Del2]Flvalpha.a, an
CC analog of Flvalpha.a, which is encoded by the same operon than
CC Flvbeta.h (PubMed:27028884). The bactericidal activity of lantibiotics
CC is based on depolarization of energized bacterial cytoplasmic
CC membranes, initiated by the formation of aqueous transmembrane pores
CC (By similarity). {ECO:0000250|UniProtKB:P86475,
CC ECO:0000269|PubMed:27028884}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC -!- PTM: Contains LL-lanthionine, DL-lanthionine, and DL-beta-
CC methyllanthionine, when coepressed in E.coli with the flavecin
CC synthetase FlvM2. {ECO:0000269|PubMed:27028884}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DQM0; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
PE 3: Inferred from homology;
KW Secreted; Thioether bond.
FT PROPEP 1..27
FT /note="Cleaved by FlvT"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450410"
FT PEPTIDE 28..65
FT /note="Lantipeptide Flvbeta.h"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450411"
FT MOD_RES 28
FT /note="2,3-didehydrobutyrine; by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT MOD_RES 30
FT /note="2,3-didehydroalanine (Ser); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT MOD_RES 44
FT /note="2,3-didehydrobutyrine; by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 29..33
FT /note="Lanthionine (Ser-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 48..54
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 56..59
FT /note="Lanthionine (Ser-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 60..63
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
SQ SEQUENCE 65 AA; 7026 MW; A22DF26CEA72E969 CRC64;
MERYGHLAGV IPVDEIDDMF ESNVIGGTSS IDCVRLASNT PEGTVNLTVR IEFCPSAACT
YSCRL